+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
DNA-Encoded Libraries: Platforms and Services Market - Product Thumbnail Image

DNA-Encoded Libraries: Platforms and Services Market

  • Report
  • January 2019
  • 133 Pages
  • Global
From
Alpha4beta7 integrin antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha4beta7 integrin antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Vestibular Schwannoma - Pipeline Insight, 2024 - Product Thumbnail Image

Vestibular Schwannoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • January 2022
  • 100 Pages
  • Global
From
Cancer Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cancer Immunotherapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Immunotherapy Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
CD 3 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CD 3 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Anti-CD3 Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD3 Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Loading Indicator